These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 33629954)
1. Open science takes on Parkinson's disease. Riley EA; Schekman R Elife; 2021 Feb; 10():. PubMed ID: 33629954 [TBL] [Abstract][Full Text] [Related]
2. Coordinating a new approach to basic research into Parkinson's disease. Schekman R; Riley EA Elife; 2019 Sep; 8():. PubMed ID: 31551111 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the progression of Parkinson's disease: a metabolic network approach. Eckert T; Tang C; Eidelberg D Lancet Neurol; 2007 Oct; 6(10):926-32. PubMed ID: 17884682 [TBL] [Abstract][Full Text] [Related]
4. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation. Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801 [TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease dementia: a neural networks perspective. Gratwicke J; Jahanshahi M; Foltynie T Brain; 2015 Jun; 138(Pt 6):1454-76. PubMed ID: 25888551 [TBL] [Abstract][Full Text] [Related]
6. The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease. Bloem BR; Marks WJ; Silva de Lima AL; Kuijf ML; van Laar T; Jacobs BPF; Verbeek MM; Helmich RC; van de Warrenburg BP; Evers LJW; intHout J; van de Zande T; Snyder TM; Kapur R; Meinders MJ BMC Neurol; 2019 Jul; 19(1):160. PubMed ID: 31315608 [TBL] [Abstract][Full Text] [Related]
9. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068 [TBL] [Abstract][Full Text] [Related]
10. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort. Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716 [TBL] [Abstract][Full Text] [Related]
11. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. Berg D; Lang AE; Postuma RB; Maetzler W; Deuschl G; Gasser T; Siderowf A; Schapira AH; Oertel W; Obeso JA; Olanow CW; Poewe W; Stern M Lancet Neurol; 2013 May; 12(5):514-24. PubMed ID: 23582175 [TBL] [Abstract][Full Text] [Related]
12. Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations. Dinov ID; Heavner B; Tang M; Glusman G; Chard K; Darcy M; Madduri R; Pa J; Spino C; Kesselman C; Foster I; Deutsch EW; Price ND; Van Horn JD; Ames J; Clark K; Hood L; Hampstead BM; Dauer W; Toga AW PLoS One; 2016; 11(8):e0157077. PubMed ID: 27494614 [TBL] [Abstract][Full Text] [Related]
13. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease. Simioni AC; Dagher A; Fellows LK Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834 [TBL] [Abstract][Full Text] [Related]
17. Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's Disease. Stephenson D; Hu MT; Romero K; Breen K; Burn D; Ben-Shlomo Y; Bhattaram A; Isaac M; Venuto C; Kubota K; Little MA; Friend S; Lovestone S; Morris HR; Grosset D; Sutherland M; Gallacher J; Williams-Gray C; Bain LJ; Avilés E; Marek K; Toga AW; Stark Y; Forrest Gordon M; Ford S J Parkinsons Dis; 2015; 5(3):581-94. PubMed ID: 26406139 [TBL] [Abstract][Full Text] [Related]
18. New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders. Bjarkam CR; Sørensen JC; Sunde NA; Geneser FA; Ostergaard K Biogerontology; 2001; 2(3):193-207. PubMed ID: 11708721 [TBL] [Abstract][Full Text] [Related]
19. The use of nonhuman primate models to understand processes in Parkinson's disease. Blesa J; Trigo-Damas I; Del Rey NL; Obeso JA J Neural Transm (Vienna); 2018 Mar; 125(3):325-335. PubMed ID: 28357564 [TBL] [Abstract][Full Text] [Related]
20. Towards model-based control of Parkinson's disease. Schiff SJ Philos Trans A Math Phys Eng Sci; 2010 May; 368(1918):2269-308. PubMed ID: 20368246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]